 |
Articles: Drug/Product Alerts |
Cocaine Alters Vesicular Dopamine Sequestration and Potassium-Stimulated Dopamine Release: The Role of D2 Receptor Activation
Journal of Pharmacology and Experimental Therapeutics, 02/25/09
Zila to Introduce ViziLite Plus in India
Zila, 02/25/09
Free full text
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation Therapy for a Psychiatric Indication in the United States
Medtronic, 02/20/09
Free full text
FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
Amgen, 02/19/09
Free full text
Illuminating Heavy Metals Testing
Pharmaceutical Technology, 02/19/09
Free full text
Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products
Journal of Pharmacy and Pharmacology, 02/18/09 Cardinal Health, FDA amend infusion pump consent decree
Cardinal Health, 02/18/09
Free full text
Antihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of leeding episodes in patients with hemophilia
Biologics: targets & therapy, 02/17/09
Evidence Based Medicine
Sandoz receives European Commission approval for biosimilar filgrastim
Novartis, 02/16/09
Free full text
Teva Announces Approval and Launch of Generic Imitrex Tablets
Teva Pharmaceutical Industries, 02/12/09
Free full text
Taro Receives FDA Approval for Levetiracetam Oral Solution
Taro Pharmaceuticals USA, 02/12/09
Free full text
Dronedarone: An antiarrhythmic agent for the management of atrial fibrillation and atrial flutter
Formulary, 02/11/09 FDA Pipeline preview, February 2009 (asenapine, certolizumab, olanzapine long-acting injection, ustekinumab, oritavancin, rotigotine, vigabatrin)
Formulary, 02/10/09 Nplate(R) Approved in the European Union for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen, 02/09/09
Free full text
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Boston Scientific, 02/06/09
Free full text
Taro Receives Final FDA Approval for Lamotrigine Chewable Tablets ANDA
Taro Pharmaceuticals USA, 02/06/09
Free full text
Copaxone is Approved for Treatment of Patients with a First Clinical Event Suggestive of Multiple Sclerosis
Teva Pharmaceutical Industries, 02/05/09
Free full text
Naglazyme Approved by Brazils National Health Surveillance Agency
BioMarin, 02/04/09
Free full text
FDA Embraces a New Review Process and Approves SNMs Multi-center IND
Applied Clinical Trials, 02/03/09
Free full text
House of Flavors Issues Allergy Alert for Undeclared Walnuts in Hanniford Chocolate Chip Ice Cream Sold at Sweetbay Supermarkets in Florida
FDA Drug Alerts, 01/30/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
106 Available Pages
|
|
